# Negative Serology by Immunoenzymatic Test (EIA) in HIV-infected Children Treated Early With Antiretroviral in the ANRS-Pediacam Study: Pathophysiological Mechanisms

> **NCT06302933** · NA · RECRUITING · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 451 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** Blood sampling

## Key facts

- **NCT ID:** NCT06302933
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-02
- **Primary completion:** 2025-08-30
- **Final completion:** 2025-08-30
- **Target enrollment:** 451 (ESTIMATED)
- **Last updated:** 2025-01-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06302933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06302933, "Negative Serology by Immunoenzymatic Test (EIA) in HIV-infected Children Treated Early With Antiretroviral in the ANRS-Pediacam Study: Pathophysiological Mechanisms". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06302933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*